West Pharmaceutical Services Profit Margin 2010-2024 | WST

Current and historical gross margin, operating margin and net profit margin for West Pharmaceutical Services (WST) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. West Pharmaceutical Services net profit margin as of March 31, 2024 is 19.42%.
West Pharmaceutical Services Annual Profit Margins
West Pharmaceutical Services Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $26.953B $2.950B
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $70.953B 18.99
Becton Dickinson (BDX) United States $66.586B 19.34
Cardinal Health (CAH) United States $25.250B 15.18
Align Technology (ALGN) United States $23.366B 45.13
Cooper (COO) United States $17.874B 27.05
Labcorp (LH) United States $16.686B 14.39
Henry Schein (HSIC) United States $9.356B 16.18
DENTSPLY SIRONA (XRAY) United States $6.293B 16.58
Merit Medical Systems (MMSI) United States $4.261B 24.38
Patterson (PDCO) United States $2.311B 11.07
STAAR Surgical (STAA) United States $2.304B 72.14
CONMED (CNMD) United States $1.906B 17.29
Atrion (ATRI) United States $0.702B 36.17
Lifevantage (LFVN) United States $0.080B 13.00
Pro-Dex (PDEX) United States $0.065B 24.61
Biolase (BIOL) United States $0.005B 0.00